5th Oct 2017 09:49
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 5 October 2017
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") | |||
Period of return | From: | 1 April 2017 | To: | 30 September 2017 |
Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 ordinary shares of 10 pence LTIP: 390,091 ordinary shares of 10 pence MIP: 310,614 ordinary shares of 10 pence EIP: 364,606 ordinary shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 ordinary shares of 10 pence LTIP: 0 ordinary shares of 10 pence MIP: 0 ordinary shares of 10 pence EIP: 0 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 ordinary shares of 10 pence LTIP: 264,814 ordinary shares of 10 pence MIP: 123,153 ordinary shares of 10 pence EIP: 284,562 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 ordinary shares of 10 pence LTIP: 125,277 ordinary shares of 10 pence MIP: 187,461 ordinary shares of 10 pence EIP: 80,044 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Stock Option Plan ("SOP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/04/2017 | - | - | 792,700 | Blocklisting return on 01/04/17 |
01/10/2017 | - | - | 792,700 | Blocklisting return on 01/10/17 |
Long Term Incentive Plan ("LTIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/04/2017 | - | - | 390,091 | Blocklisting return on 01/04/17 |
06/04/2017 | 0 | 8,000 | 382,091 |
|
11/04/2017 | 0 | 65,995 | 316,096 |
|
30/05/2017 | 0 | 90,252 | 225,844 |
|
11/06/2017 | 0 | 96,220 | 129,624 |
|
18/06/2017 | 0 | 4,347 | 125,277 |
|
01/10/2017 | - | - | 125,277 | Blocklisting return on 01/10/17 |
Management Incentive Plan ("MIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/04/2017 | - | - | 310,614 | Blocklisting return on 01/04/17 |
17/05/2017 | 0 | 117,709 | 192,905 |
|
21/06/2017 | 0 | 1,340 | 191,565 |
|
08/08/2017 | 0 | 4,104 | 187,461 |
|
01/10/2017 | - | - | 187,461 | Blocklisting return on 01/10/17 |
Executive Incentive Plan ("EIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/04/2017 | - | - | 364,606 | Blocklisting return on 01/04/17 |
12/04/2017 | 0 | 213,562 | 151,044 |
|
17/05/2017 | 0 | 71,000 | 80,044 |
|
01/10/2017 | - | - | 80,044 | Blocklisting return on 01/10/17 |
Related Shares:
Hikma Pharmaceuticals